Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 30, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: Information on the total number of voting rights and shares

Regulated information Gosselies, Belgium, 30 December 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative...
December 20, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics annonce l’avancée de JTA-004 vers une étude pivot de Phase III

Communiqué de presse Soumission d’une demande d'essai clinique pour l'étude pivotale de Phase III JTA-004 Initiation du recrutement des patients prévue début 2020 et résultats attendus au...
December 20, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics advances JTA-004 into pivotal Phase III study

Press release Clinical trial application for pivotal JTA-004 Phase III study submitted Start patient enrollment anticipated early 2020 with topline results expected in Q2 2021 Gosselies,...
December 19, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics annonce la nomination du Dr. Miguel Forte en tant que Directeur Général, afin de mener la Société dans la prochaine phase de Développement

Information réglementée Gosselies, Belgique, le 19 décembre 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le...
December 19, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics announces the appointment of Dr. Miguel Forte as CEO to lead the Company into the next phase of development

Regulated information Gosselies, Belgium, 19 December 2019, 7am CET– BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative...
December 09, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA : Notification de transparence reçue de la part de S.R.I.W. SA et Sofipôle SA

Information réglementée Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes Gosselies, Belgique, le 9 décembre 2019, 07h00 CET - BONE...
December 09, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Regulated information Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 9 December 2019, 7am CET – BONE THERAPEUTICS (Euronext...
November 29, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions

Information réglementée Gosselies, Belgique, le 29 novembre 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le...
November 29, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: Information on the total number of voting rights and shares

Regulated information Gosselies, Belgium, 29 November 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative...
November 25, 2019 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 12 December 2019 have been made available

Regulated information Gosselies, Belgium, 25 November 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative...